Nivolumab vs Trimethoprim
Nivolumab vs Trimethoprim: Overview
This comparison examines the pharmacological differences between Nivolumab and Trimethoprim.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).
Pharmacokinetics
Half-life: Nivolumab — 27 days; Trimethoprim — 8-10 hours.
Chemical Properties
Molecular Formula: Trimethoprim — C14H18N4O3.
Molecular Weight: Trimethoprim — 290.3180 g/mol.
Type: Nivolumab — Antibody; Trimethoprim — Small molecule.